We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
48 hedge funds and large institutions have $211M invested in Evelo Biosciences, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
91% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 11
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
5% more capital invested
Capital invested by funds: $200M → $211M (+$10.8M)
2% more funds holding
Funds holding: 47 → 48 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
0.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
6
Increased
21
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.05M |
| 2 |
Millennium Management
New York
|
+$576K |
| 3 |
BlackRock
New York
|
+$536K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$323K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$226K |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$6.13M |
| 2 |
AG
Artal Group
Luxembourg
|
-$873K |
| 3 |
CCM
CAAS Capital Management
New York
|
-$420K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$336K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$111K |
